Search hospitals > Missouri > Kansas City
University of Kansas Cancer Center
Claim this profileKansas City, Missouri 64131
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Stomach Cancer
Conducts research for T-Lymphoblastic Leukemia/Lymphoma
Conducts research for Lung Cancer
435 reported clinical trials
47 medical researchers
Summary
University of Kansas Cancer Center is a medical facility located in Kansas City, Missouri. This center is recognized for care of Skin Cancer, Breast Cancer, Stomach Cancer, T-Lymphoblastic Leukemia/Lymphoma, Lung Cancer and other specialties. University of Kansas Cancer Center is involved with conducting 435 clinical trials across 586 conditions. There are 47 research doctors associated with this hospital, such as Jun Zhang, Chao H. Huang, Anwaar Saeed, and Gary C. Doolittle.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Jun ZhangHouston Methodist Hospital5 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
28 reported clinical trials
43 drugs studied
Chao H. HuangUniversity of Kansas Health System Saint Francis Campus6 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
22 reported clinical trials
35 drugs studied
Anwaar SaeedUniversity of Kansas Cancer Center3 years of reported clinical research
Studies Colorectal Cancer
Studies Stomach Cancer
20 reported clinical trials
37 drugs studied
Gary C. DoolittleSalina Regional Health Center2 years of reported clinical research
Studies Skin Cancer
Studies Lung Cancer
20 reported clinical trials
36 drugs studied
Clinical Trials running at University of Kansas Cancer Center
Skin Cancer
Breast Cancer
Lung Cancer
Lymphoma
Breast cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Acute Myeloid Leukemia
Squamous Cell Carcinoma
Bladder Cancer
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Naporafenib + Trametinib
for Melanoma
Stage 1: To select the optimal dose of naporafenib + trametinib to be studied in Stage 2. Stage 2: To compare progression free survival (PFS) and overall survival (OS) for patients with NRAS-mutant (NRASm) melanoma who are randomized to receive the combination of naporafenib + trametinib to that of patients who are randomized to physician's choice of therapy (dacarbazine, temozolomide, or trametinib monotherapy).
Recruiting2 awards Phase 34 criteria
Focused Radiation vs Systemic Therapy
for Kidney Cancer
This phase III trial compares the effect of stero-ablative radiotherapy (SAbR) followed by standard of care systemic therapy, to standard of care systemic therapy alone, in patients with kidney cancer that has spread from where it first started (primary site) to a limited (2-5) number of places in the body (metastatic). Study doctors want to find out if this approach is better or worse than the usual approach for metastatic kidney cancer. The usual approach is defined as the care most people get for metastatic kidney cancer which includes systemic therapy such as immunotherapy (given through the veins) and/or small molecular inhibitor (tablets taken by mouth). Radiotherapy uses high energy x-rays to kill cancer cells and shrink tumors. SAbR uses special equipment to position a patient and deliver radiation to tumors with high precision. Giving SAbR prior to systemic therapy may kill more tumor cells than the usual approach, which is systemic therapy alone.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University of Kansas Cancer Center?
University of Kansas Cancer Center is a medical facility located in Kansas City, Missouri. This center is recognized for care of Skin Cancer, Breast Cancer, Stomach Cancer, T-Lymphoblastic Leukemia/Lymphoma, Lung Cancer and other specialties. University of Kansas Cancer Center is involved with conducting 435 clinical trials across 586 conditions. There are 47 research doctors associated with this hospital, such as Jun Zhang, Chao H. Huang, Anwaar Saeed, and Gary C. Doolittle.
Where is University of Kansas Cancer Center located?
The University of Kansas Cancer Center offers comprehensive medical oncology services at its facility located at 12200 West 110th Street, Overland Park, KS 66210. For inquiries or to schedule an appointment, please call 913-588-1227.
Who should I call to ask about financial aid or insurance network?
The University of Kansas Cancer Center offers comprehensive support services for cancer patients, including emotional, nutritional, financial, and genetic counseling, personal appearance services, and rehabilitation. Patients eligible for financial assistance, with a gross family income between 0% to 300% of the federal poverty guidelines, can apply through the University of Kansas Health System. For more details or to make an appointment, contact 913-588-1227 or toll-free at 844-323-1227.
What insurance does University of Kansas Cancer Center accept?
The University of Kansas Cancer Center accepts a wide range of insurance plans, including those through the University of Kansas Medical Center for its employees, covering medical, dental, vision, disability, long-term care, life insurance, and wellness programs. Additionally, it accepts various plans on the open marketplace, including Aetna CareLink, BCBS Kansas, Sunflower or Home State/Ambetter, Oscar, and Blue Cross Blue Shield of Kansas City/Blue Select. It's important to verify with your physician that they participate with your insurance plan or network before seeking services.
What awards or recognition has University of Kansas Cancer Center received?
The University of Kansas Cancer Center, located in Kansas City, Missouri, is recognized as a Comprehensive cancer center by the National Cancer Institute (NCI), a prestigious status shared with only 53 centers nationwide. This distinction is accompanied by a five-year, $13.8 million grant aimed at bolstering the center's research efforts. In partnership with the Stowers Institute for Medical Research and Children's Mercy Kansas City, the center enhances its research capabilities and extends its services to high-risk and underserved communities.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.